Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Moride

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Neurology|March 17, 2012
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitorsA Pariente, A Fourrier-Réglat, F Bazin, et al.
The New England Journal of Medicine|August 29, 1996
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study GroupL Abenhaim, Y Moride, F Brenot, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2007
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) studyF Depont, A Fourrier, Y Merlière, et al.
BMJ (Clinical Research Ed.)|June 22, 1996
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysisD Henry, L L Lim, L A Garcia Rodriguez, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Neurology|March 17, 2012
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitorsA Pariente, A Fourrier-Réglat, F Bazin, et al.
The New England Journal of Medicine|August 29, 1996
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study GroupL Abenhaim, Y Moride, F Brenot, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2007
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) studyF Depont, A Fourrier, Y Merlière, et al.
BMJ (Clinical Research Ed.)|June 22, 1996
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysisD Henry, L L Lim, L A Garcia Rodriguez, et al.
Pageof 3